UHealth is the First Academic Medical Center to Use New da Vinci Surgical System
Building on its growing reputation as a leader in the use of breakthrough technology, UHealth - University of Miami Health System has become the first academic medical center in the world to use the new da Vinci® Xi™ Surgical System. The procedure, a prostatectomy, was performed by Dipen Parekh, M.D., at University of Miami Hospital, the flagship hospital of UHealth.
Research Finds Link Between Aortic Valve Replacement and Atrial Fibrillation
A team of Miller School researchers has found a strong correlation between the type of aortic valve replacement procedure a patient undergoes and the development of post-operative atrial fibrillation. Their findings are reported in an article, “New-Onset Atrial Fibrillation After Aortic Valve Replacement,” that appears in the April 22 issue of the Journal of the American College of Cardiology.
UMH Achieves Highest Level for Epilepsy Care
The International Comprehensive Epilepsy Center at University of Miami Hospital has been designated as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers. The designation is the highest level awarded by the association, which evaluates the quality of specialized epilepsy care in the United States.
Alan Livingstone, M.D., Inducted into Brazil’s National Academy of Medicine
Alan S. Livingstone, M.D., the Lucille and DeWitt Daughtry Professor and Chairman of Surgery, is usually addressed as “Dr. Livingstone,” sometimes as “Professor Livingstone.” Now there is a new option: “Your Excellency.” On March 27, Livingstone was inducted into Brazil’s National Academy of Medicine, one of the oldest and most exclusive medical academies in the world, and the title accompanies that honor.
Discovery Scientists Receive NIH Funding for Spinal Cord Injury Therapy
A group of Miller School scientists has received a $1.6 million small business award from the National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health, to support development and clinical trials of a novel anti-inflammatory antibody treatment for human spinal cord injury.